Normalization of Overexpressed α-Synuclein Causing Parkinson's Disease By a Moderate Gene Silencing With RNA Interference
Open Access
- 1 January 2015
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 4 (5) , e241
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Disease-Causing Allele-Specific Silencing by RNA InterferencePharmaceuticals, 2013
- An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neuronsBrain Research, 2011
- Tailor-made RNAi knockdown against triplet repeat disease-causing allelesProceedings of the National Academy of Sciences, 2010
- The effect of SNCA 3′ region on the levels of SNCA-112 splicing variantneurogenetics, 2010
- SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein LevelArchives of Neurology, 2010
- In Vivo RNAi-Mediated α-Synuclein Silencing Induces Nigrostriatal DegenerationMolecular Therapy, 2010
- Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAsNucleic Acids Research, 2009
- Heat Shock Transcription Factor 1-activating Compounds Suppress Polyglutamine-induced Neurodegeneration through Induction of Multiple Molecular ChaperonesJournal of Biological Chemistry, 2008
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998